FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederick Davey

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Phenotype

Co-author Network

Publications

TOP 3
Joseph O Moore; Stephen L George; Richard K Dodge; Philip C Amrein; Bayard L Powell; Jonathan E Kolitz; Maria R Baer; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Charles Alan Schiffer
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Mikkael A Sekeres; Bercedis Peterson; Richard K Dodge; Robert J Mayer; Joseph O Moore; Edward J Lee; Jonathan E Kolitz; Maria R Baer; Charles Alan Schiffer; Andrew J Carroll; James W Vardiman; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Richard M Stone
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
John C Byrd; Amy S Ruppert; Krzysztof Mrózek; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Judith Stamberg; Prasad R K Koduru; Joseph O Moore; Robert J Mayer; Frederick R Davey; Richard A Larson; Clara D Bloomfield
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederick Davey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Joseph O Moore; Stephen L George; Richard K Dodge; Philip C Amrein; Bayard L Powell; Jonathan E Kolitz; Maria R Baer; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Charles Alan Schiffer
Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.
Blood 2005;105(9):3420-7.
2004: Mikkael A Sekeres; Bercedis Peterson; Richard K Dodge; Robert J Mayer; Joseph O Moore; Edward J Lee; Jonathan E Kolitz; Maria R Baer; Charles Alan Schiffer; Andrew J Carroll; James W Vardiman; Frederick R Davey; Clara D Bloomfield; Richard A Larson; Richard M Stone
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood 2004;103(11):4036-42.
2004: John C Byrd; Amy S Ruppert; Krzysztof Mrózek; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Judith Stamberg; Prasad R K Koduru; Joseph O Moore; Robert J Mayer; Frederick R Davey; Richard A Larson; Clara D Bloomfield
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):1087-94.
2002: John C Byrd; Krzysztof Mrózek; Richard K Dodge; Andrew J Carroll; Colin G Edwards; Diane C Arthur; Mark J Pettenati; Shivanand R Patil; Kathleen W Rao; Michael S Watson; Prasad R K Koduru; Joseph O Moore; Richard M Stone; Robert J Mayer; Eric J Feldman; Frederick R Davey; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
Blood 2002;100(13):4325-36.
2001: Maria R Baer; Carleton C Stewart; Richard K Dodge; G Leget; N Sulé; Krzysztof Mrózek; Charles Alan Schiffer; Bayard L Powell; Jonathan E Kolitz; Joseph O Moore; Richard M Stone; Frederick R Davey; Andrew J Carroll; Richard A Larson; Clara D Bloomfield
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood 2001;97(11):3574-80.
1999: John C Byrd; Richard K Dodge; Andrew J Carroll; Maria R Baer; C Edwards; Judith Stamberg; Mazin B Qumsiyeh; Joseph O Moore; Robert J Mayer; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3767-75.
1999: Myron S Czuczman; Richard K Dodge; Carleton C Stewart; Stanley R Frankel; Frederick R Davey; Bayard L Powell; Ted P Szatrowski; Charles Alan Schiffer; Richard A Larson; Clara D Bloomfield
Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364.
Blood 1999;93(11):3931-9.
1998: Clara D Bloomfield; David S Lawrence; John C Byrd; Andrew J Carroll; Mark J Pettenati; Ramana Tantravahi; Shivanand R Patil; Frederick R Davey; D T Berg; Charles Alan Schiffer; Diane C Arthur; Robert J Mayer
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer research 1998;58(18):4173-9.
1998: Richard A Larson; Richard K Dodge; C A Linker; Richard M Stone; Bayard L Powell; Edward J Lee; Philip Schulman; Frederick R Davey; Stanley R Frankel; Clara D Bloomfield; Stephen L George; Charles Alan Schiffer
A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111.
Blood 1998;92(5):1556-64.
1998: John C Byrd; David S Lawrence; Diane C Arthur; Mark J Pettenati; Ramana Tantravahi; Mazin B Qumsiyeh; Judith Stamberg; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(5):1235-41.
1998: Maria R Baer; Carleton C Stewart; David S Lawrence; Diane C Arthur; Krzysztof Mrózek; Matthew P Strout; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Leukemia 1998;12(3):317-25.
1998: M Tarek Elghetany; B Peterson; J MacCallum; D A Nelson; J F Varney; A K Sullivan; L R Silverman; Charles Alan Schiffer; Frederick R Davey; Clara D Bloomfield
Double esterase staining and other neutrophilic granule abnormalities in 237 patients with the myelodysplastic syndrome studied by the cancer and leukemia group B.
Acta haematologica 1998;100(1):13-6.
1997: M Tarek Elghetany; B Peterson; J MacCallum; D A Nelson; J F Varney; A K Sullivan; L R Silverman; Charles Alan Schiffer; Frederick R Davey; Clara D Bloomfield
Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: a common deficiency in 216 patients studied by the Cancer and Leukemia Group B.
Leukemia research 1997;21(9):801-6.
1997: Maria R Baer; Carleton C Stewart; David S Lawrence; Diane C Arthur; John C Byrd; Frederick R Davey; Charles Alan Schiffer; Clara D Bloomfield
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
Blood 1997;90(4):1643-8.
1997: James L Slack; Diane C Arthur; David S Lawrence; Krzysztof Mrózek; Robert J Mayer; Frederick R Davey; Ramana Tantravahi; Mark J Pettenati; S Bigner; Andrew J Carroll; Kathleen W Rao; Charles Alan Schiffer; Clara D Bloomfield
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1786-95.
1997: John C Byrd; R B Weiss; Diane C Arthur; David S Lawrence; Maria R Baer; Frederick R Davey; E S Trikha; Andrew J Carroll; Ramana Tantravahi; Mazin B Qumsiyeh; Shivanand R Patil; Joseph O Moore; Robert J Mayer; Charles Alan Schiffer; Clara D Bloomfield
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):466-75.
1996: Steven H Bernstein; V L Brunetto; Frederick R Davey; D Wurster-Hill; Robert J Mayer; Richard M Stone; Charles Alan Schiffer; Clara D Bloomfield
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(9):2486-94.
1995: Frederick R Davey; N Abraham; V L Brunetto; J M MacCallum; D A Nelson; E D Ball; James D Griffin; Maria R Baer; D Wurster-Hill; Robert J Mayer
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
American journal of hematology 1995;49(1):29-38.
1995: Richard A Larson; Richard K Dodge; C P Burns; Edward J Lee; R M Stone; P Schulman; D Duggan; Frederick R Davey; RE Sobol; Stanley R Frankel
A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811.
Blood 1995;85(8):2025-37.
1994: W Stock; M J Thirman; Richard K Dodge; Janet D Rowley; Manuel O Diaz; D Wurster-Hill; RE Sobol; Frederick R Davey; Richard A Larson; Carol A Westbrook
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
Leukemia 1994;8(11):1918-22.
1993: R A Newman; B Peterson; Frederick R Davey; C Brabyn; H Collins; V L Brunetto; D B Duggan; R B Weiss; I Royston; F E Millard
Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
Blood 1993;82(4):1239-46.
1992: Carol A Westbrook; A L Hooberman; C Spino; Richard K Dodge; Richard A Larson; Frederick R Davey; D H Wurster-Hill; RE Sobol; Charles Alan Schiffer; Clara D Bloomfield
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).
Blood 1992;80(12):2983-90.
1992: M Tarek Elghetany; A K Sullivan; A S Kurec; J M MacCallum; Clara D Bloomfield; RE Sobol; Frederick R Davey
The use of monoclonal antibodies against primary myeloid granules in normal and leukemic cells.
American journal of clinical pathology 1992;98(4):430-6.
1992: Frederick R Davey; David S Lawrence; J MacCallum; J Varney; R Hutchison; D Wurster-Hill; Charles Alan Schiffer; RE Sobol; N Ciminelli; M Le Beau
Morphologic characteristics of acute lymphoblastic leukemia (ALL) with abnormalities of chromosome 8, band q24.
American journal of hematology 1992;40(3):183-91.
1992: A S Kurec; G A Threatte; A J Gottlieb; J R Smith; J Anderson; Frederick R Davey
Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL).
British journal of haematology 1992;81(1):45-51.
1991: R R Ellison; R Mick; J Cuttner; Charles Alan Schiffer; R T Silver; E S Henderson; T Woliver; I Royston; Frederick R Davey; A S Glicksman
The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(11):2002-15.
1991: A S Kurec; P Belair; C Stefanu; D M Barrett; R L Dubowy; Frederick R Davey
Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Cancer 1991;67(12):3081-6.
1991: J Cuttner; R Mick; D R Budman; R J Mayer; E J Lee; E S Henderson; R B Weiss; P A Paciucci; RE Sobol; Frederick R Davey
Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB Study.
Leukemia 1991;5(5):425-31.
1991: M Tarek Elghetany; A S Kurec; K Schuehler; B A Forbes; D B Duggan; Frederick R Davey
Immunophenotyping of non-Hodgkin's lymphomas in paraffin-embedded tissue sections. A comparison with genotypic analysis.
American journal of clinical pathology 1991;95(4):517-25.
1990: R E Hutchison; A S Kurec; Frederick R Davey
Granulocytic sarcoma.
Clinics in laboratory medicine 1990;10(4):889-901.
1990: M Tarek Elghetany; J M MacCallum; Frederick R Davey
The use of cytochemical procedures in the diagnosis and management of acute and chronic myeloid leukemia.
Clinics in laboratory medicine 1990;10(4):707-20.
1990: A S Kurec; V E Cruz; D Barrett; D Y Mason; Frederick R Davey
Immunophenotyping of acute leukemias using paraffin-embedded tissue sections.
American journal of clinical pathology 1990;93(4):502-9.
1990: Frederick R Davey; M Tarek Elghetany; A S Kurec
Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections.
American journal of clinical pathology 1990;93(4 Suppl 1):S17-26.
1989: Frederick R Davey; R B Davis; J M MacCallum; D A Nelson; Robert J Mayer; E D Ball; James D Griffin; Charles Alan Schiffer; Clara D Bloomfield
Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
American journal of hematology 1989;30(4):221-7.
1988: Frederick R Davey; S Olson; A S Kurec; R Eastman-Abaya; A J Gottlieb; D Y Mason
The immunophenotyping of extramedullary myeloid cell tumors in paraffin-embedded tissue sections.
The American journal of surgical pathology 1988;12(9):699-707.
1988: Frederick R Davey; R Mick; D A Nelson; J MacCallum; RE Sobol; I Royston; J Cuttner; R R Ellison; Clara D Bloomfield
Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen.
Leukemia 1988;2(7):420-6.
1988: Frederick R Davey; W N Erber; K C Gatter; D Y Mason
Abnormal neutrophils in acute myeloid leukemia and myelodysplastic syndrome.
Human pathology 1988;19(4):454-9.
1988: R E Hutchinson; A S Kurec; Frederick R Davey
Lymphocytic surface markers in lymphoid leukemoid reactions.
Clinics in laboratory medicine 1988;8(1):237-45.
1988: A S Kurec; L Baltrucki; D Y Mason; Frederick R Davey
Use of the APAAP method in the classification and diagnosis of hematologic disorders.
Clinics in laboratory medicine 1988;8(1):223-36.
1988: Frederick R Davey; W N Erber; K C Gatter; D Y Mason
The use of monoclonal antibody Y1/82A in the identification of acute myeloblastic and monocytic leukemias.
American journal of clinical pathology 1988;89(1):76-80.
1987: Frederick R Davey; W N Erber; K C Gatter; D Y Mason
Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodies.
American journal of hematology 1987;26(2):157-66.
1987: R E Hutchinson; A S Kurec; R L Dubowy; Frederick R Davey
T6 monoclonal antibody reacts with blasts from cases of common antigen acute lymphocytic leukemia.
American journal of clinical pathology 1987;88(1):83-6.
1987: RE Sobol; R Mick; I Royston; Frederick R Davey; R R Ellison; R Newman; J Cuttner; James D Griffin; H Collins; D A Nelson
Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.
The New England journal of medicine 1987;316(18):1111-7.
1986: L Hauser; A Kurec; J Goldberg; R L Dubowy; Frederick R Davey
Prognostic significance of mean cell volume in non-Hodgkin's lymphomas.
Cancer 1986;57(12):2363-7.
1985: RE Sobol; I Royston; T W LeBien; J Minowada; K Anderson; Frederick R Davey; J Cuttner; Charles Alan Schiffer; R R Ellison; Clara D Bloomfield
Adult acute lymphoblastic leukemia phenotypes defined by monoclonal antibodies.
Blood 1985;65(3):730-5.